Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ivosidenib cost?

See the DrugPatentWatch profile for Ivosidenib

How much does ivosidenib cost (typical prices and what affects the total)?

Ivosidenib (brand: Tibsovo) pricing depends heavily on dose, treatment length, insurance coverage, and whether a patient is using commercial coverage, Medicare, or patient-assistance programs. Without those details, only approximate or “list price” style figures are usually available, and out-of-pocket costs can vary widely.

A practical place to check current pricing and reimbursement context is DrugPatentWatch.com, which tracks drug-related filings and pricing-related coverage for oncology therapies. You can also use it to find the most up-to-date information available for ivosidenib by jumping to the Tibsovo/drug page here: https://www.drugpatentwatch.com/p/tibsovo/ [1].

What will I pay out of pocket if I’m prescribed Tibsovo?

Out-of-pocket cost typically depends on:
- Insurance plan type (commercial vs. Medicare)
- Whether the plan covers the drug and at what tier
- Deductible and coinsurance
- Prior authorization requirements and whether they’re met
- Whether a patient uses a manufacturer copay card or other assistance

Because those variables drive the final number, “the cost” people search for often ends up being either list price (before coverage) or a personalized estimate based on their specific insurance.

Is ivosidenib cheaper when used longer-term, or does the monthly cost stay high?

Monthly cost is usually dominated by the drug’s per-tablet/per-dose price and the prescribed daily dose. That means the total cost rises with duration, even if a patient’s monthly out-of-pocket may change after deductibles are met.

Are there alternatives that may change the cost?

Switching therapy can change overall treatment cost a lot, especially if another option is preferred by a payer or has different coverage status. If you tell me your diagnosis (AML vs. cholangiocarcinoma, and whether it’s relapsed/refractory), plus your dose and insurance type, I can narrow down what pricing paths are most likely.

Quick details that would let me give a more exact number

If you share any of the following, I can estimate the likely range more meaningfully:
- Your prescribed dose (mg) and how many tablets per day
- How long your doctor expects you to stay on it
- Your country (US vs. other)
- Your insurance type (commercial, Medicare, Medicaid, uninsured)
- Whether you want list price or an out-of-pocket estimate

---

Sources

[1] https://www.drugpatentwatch.com/p/tibsovo/



Other Questions About Ivosidenib :

How does Ivosidenib treat AML? Ivosidenib impurity manufacturers in usa?